13 Results

People

  1. Drilon
    Drilon
  2. Rimner
    Rimner
  3. Gomez
    Gomez
  4. Li
    Li
  5. Isbell
    Isbell
  6. Jones
    Jones
  7. Lebow
    Lebow
  8. Rusch
    Rusch
  9. Zhang
    Zhang
  10. Arcila
    Arcila

Groups

  1. Department of Medicine (13)
  2. Radiation Oncology, Department of (13)
  3. Solid Tumor Oncology Division (13)
  4. Thoracic Oncology (13)
  5. Biostatistics Service (10)
  6. Epidemiology and Biostatistics (10)
  7. GME, Radiation Oncology (9)
  8. Graduate Medical Education (9)
  9. GSK Faculty (8)
  10. Surgery (8)
  1. "Alexander Drilon"
  2. "Thoracic Oncology"
  3. "Andreas Rimner"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (5)
Groups
  1. Department of Medicine (13)
  2. Radiation Oncology, Department of (13)
  3. Solid Tumor Oncology Division (13)
  4. Thoracic Oncology (13)
  5. Biostatistics Service (10)
  6. Epidemiology and Biostatistics (10)

More Groups

People
  1. Alexander Drilon (13)
  2. Andreas Rimner (13)
  3. Daniel Gomez (8)
  4. Bob Li (7)
  5. Emily Lebow (7)
  6. Charles Rudin (6)

More People

Years
  1. 2023 (1)
  2. 2022 (4)
  3. 2021 (2)
  4. 2020 (1)
  5. 2019 (2)
  6. 2018 (1)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (4)
  2. Journal of Thoracic Oncology (2)
  3. Lung Cancer (2)
  4. JCO Precision Oncology (1)
  5. JNCI: Journal of the National Cancer Institute (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. Elsevier Inc. (6)
  2. American Society of Clinical Oncology (2)
  3. Elsevier Ireland Ltd. (2)
  4. Oxford University Press (2)
  5. Nature Publishing Group (1)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization of central nervous system clinico-genomic outcomes in ALK-positive non-small cell lung cancer patients with brain metastases treated with alectinib
    Journal Article

    Miao, E.; Eichholz, J. E.; Lebow, E. S.; Flynn, J.; Zhang, Z.; Walch, H.; Hubbeling, H.; Beal, K.; Moss, N. S.; Yu, K. K.; more...
    Lung Cancer (2023)

    Fulltext@MSK | Save
  • Outcomes with local therapy and tyrosine kinase inhibition in patients with ALK/ROS1/RET-rearranged lung cancers
    Journal Article

    Hubbeling, H.; Choudhury, N.; Flynn, J.; Zhang, Z. G.; Falcon, C.; Rusch, V. W.; Park, B. J.; Ziv, E.; Shaverdian, N.; Gelblum, D. Y.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Genomic alterations in ALK fusion-positive non-small cell lung cancer (NSCLC) patients with brain metastases
    Meeting Abstract

    Eichholz, J.; Miao, E.; Lebow, E.; Walch, H.; Flynn, J.; Zhang, Z.; Hubbeling, H.; Beal, K.; Moss, N.; Yu, K.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • CNS outcomes in ALK fusion positive NSCLC patients with BM who received alectinib with or without local therapy
    Meeting Abstract

    Miao, E.; Lebow, E. S.; Eichholz, J.; Flynn, J.; Zhang, Z.; Hubbeling, H. G.; Beal, K.; Moss, N. S.; Yu, K.; Yang, J. T.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Outcomes with local therapy and tyrosine kinase inhibition in patients with ALK/ROS1/RET-rearranged lung cancers
    Meeting Abstract

    Hubbeling, H. G.; Choudhury, N.; Falcon, C.; Rusch, V. W.; Park, B.; Ziv, E.; Shaverdian, N.; Gelblum, D.; Shepherd, A. F.; Simone, C. B. 2nd; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions
    Journal Article

    Mondaca, S.; Lebow, E. S.; Namakydoust, A.; Razavi, P.; Reis-Filho, J. S.; Shen, R.; Offin, M.; Tu, H. Y.; Murciano-Goroff, Y.; Xu, C.; more...
    Lung Cancer (2021)

    Fulltext@MSK | Save
  • Circulating tumor DNA as a biomarker in oligometastatic non-small cell lung cancer
    Meeting Abstract

    Lebow, E. S.; Murciano-Goroff, Y.; Razavi, P.; Reis, J. S.; Flynn, J.; Zhang, Z.; Tu, H. Y.; Bertucci, C.; Lim, L. P.; Li, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • A clinical utility study of plasma DNA next generation sequencing guided treatment of uncommon drivers in advanced non-small-cell lung cancers
    Meeting Abstract

    Tu, H.; Xu, C.; Tong-Li, C.; Offin, M.; Razavi, P.; Schapira, E.; Namakydoust, A.; Lee, A.; Pavlakis, N.; Clarke, S.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • A prospective study of circulating tumor DNA to guide matched targeted therapy in lung cancers
    Journal Article

    Sabari, J. K.; Offin, M.; Stephens, D.; Ni, A.; Lee, A.; Pavlakis, N.; Clarke, S.; Diakos, C. I.; Datta, S.; Tandon, N.; more...
    JNCI: Journal of the National Cancer Institute (2019)

    Fulltext@MSK | Save